Skip to main content
Signal8

Bir Dawn Carter

SEC insider (Form 3/4/5 filer). CIK 0001688712. Director at GERON CORP (GERN) and 2 other issuers. 5 reported Form 4/5 transactions since Sep 2024; latest on May 20, 2026. Located in REDWOOD CITY, CA.

Companies Bir Dawn Carter has filed insider reports for

  • GERON CORP (GERN): Director
  • SOLENO THERAPEUTICS INC (SLNO): Director
  • CASSAVA SCIENCES INC (SAVA): Director
Bir Dawn Carter profile photo

Bir Dawn Carter

CIK: 0001688712

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (80.0%)

Compensation grants

Other (G, F, J, C, D, …)1 (20.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (3)

GERON CORP logo
GERN

GERON CORP

Director
SOLENO THERAPEUTICS INC logo
SLNO

SOLENO THERAPEUTICS INC

Director
CASSAVA SCIENCES INC logo
SAVA

CASSAVA SCIENCES INC

Director

Discretionary Trading P&L

Holdings

Transaction History (5 total)

  • GERON CORP logo
    GERN

    GERON CORP

    May 20, 2026
    Award

    Stock Option (right to buy)

    Direct
    220K shares-
  • SOLENO THERAPEUTICS INC logo
    SLNO

    SOLENO THERAPEUTICS INC

    May 18, 2026
    Disposition
    Direct
    17K shares-
  • CASSAVA SCIENCES INC logo
    SAVA

    CASSAVA SCIENCES INC

    Oct 21, 2025
    Award

    Stock Option (Right to Buy)

    Direct
    53K shares-
  • SOLENO THERAPEUTICS INC logo
    SLNO

    SOLENO THERAPEUTICS INC

    Jun 5, 2025
    Award
    Direct
    4K shares-
  • GERON CORP logo
    GERN

    GERON CORP

    May 21, 2025
    Award

    Stock Option (right to buy)

    Direct
    180K shares-

1-5 of 5